Pacific Bio (PACB) Reports Q4 Revenues of $24.9 Million

Pacific Bio (NASDAQ: PACB) reported Q4 revenue of $24.9 million, versus $24.4 million reported last year.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c